Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Claggett

Showing results (321-330 of 362) with videos related to

Pageof 37
Sort By:
JAMA Cardiology|March 27, 2024
Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection FractionKirsty McDowell, Toru Kondo, Atefeh Talebi, et al.
JACC. Heart Failure|November 9, 2024
The Clinical Trajectory of NYHA Functional Class I Patients With Obstructive Hypertrophic CardiomyopathyMonica Ahluwalia, Jiankang Liu, Iacopo Olivotto, et al.
Circulation|November 20, 2014
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trialMarc A Pfeffer, Brian Claggett, Susan F Assmann, et al.
Journal of Cardiac Failure|March 7, 2023
Missense Genetic Variation of ICAM1 and Incident Heart FailurePedro Giro, Jonathan W Cunningham, Laura Rasmussen-Torvik, et al.
European Heart Journal|May 23, 2023
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trialSafia Chatur, Muthiah Vaduganathan, Brian Claggett, et al.
Journal of the American College of Cardiology|January 31, 2024
Large-Scale Proteomics Identifies Novel Biomarkers and Circulating Risk Factors for Aortic StenosisKhaled Shelbaya, Victoria Arthur, Yimin Yang, et al.
The Lancet. Digital Health|December 8, 2023
Electrocardiographic deep learning for predicting post-procedural mortality: a model development and validation studyDavid Ouyang, John Theurer, Nathan R Stein, et al.
European Journal of Heart Failure|November 7, 2023
Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trialMorten Schou, Brian Claggett, Zi Michael Miao, et al.
The New England Journal of Medicine|April 11, 2014
Spironolactone for heart failure with preserved ejection fractionBertram Pitt, Marc A Pfeffer, Susan F Assmann, et al.
JACC. Asia|February 19, 2024
Effects of Dapagliflozin in Patients in Asia: A Post Hoc Subgroup Analysis From the DELIVER TrialXiaowen Wang, Carolyn S P Lam, Muthiah Vaduganathan, et al.
Pageof 37

Showing results (321-330 of 362) with videos related to

Sort By:
Pageof 37
JAMA Cardiology|March 27, 2024
Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection FractionKirsty McDowell, Toru Kondo, Atefeh Talebi, et al.
JACC. Heart Failure|November 9, 2024
The Clinical Trajectory of NYHA Functional Class I Patients With Obstructive Hypertrophic CardiomyopathyMonica Ahluwalia, Jiankang Liu, Iacopo Olivotto, et al.
Circulation|November 20, 2014
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trialMarc A Pfeffer, Brian Claggett, Susan F Assmann, et al.
Journal of Cardiac Failure|March 7, 2023
Missense Genetic Variation of ICAM1 and Incident Heart FailurePedro Giro, Jonathan W Cunningham, Laura Rasmussen-Torvik, et al.
European Heart Journal|May 23, 2023
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trialSafia Chatur, Muthiah Vaduganathan, Brian Claggett, et al.
Journal of the American College of Cardiology|January 31, 2024
Large-Scale Proteomics Identifies Novel Biomarkers and Circulating Risk Factors for Aortic StenosisKhaled Shelbaya, Victoria Arthur, Yimin Yang, et al.
The Lancet. Digital Health|December 8, 2023
Electrocardiographic deep learning for predicting post-procedural mortality: a model development and validation studyDavid Ouyang, John Theurer, Nathan R Stein, et al.
European Journal of Heart Failure|November 7, 2023
Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trialMorten Schou, Brian Claggett, Zi Michael Miao, et al.
The New England Journal of Medicine|April 11, 2014
Spironolactone for heart failure with preserved ejection fractionBertram Pitt, Marc A Pfeffer, Susan F Assmann, et al.
JACC. Asia|February 19, 2024
Effects of Dapagliflozin in Patients in Asia: A Post Hoc Subgroup Analysis From the DELIVER TrialXiaowen Wang, Carolyn S P Lam, Muthiah Vaduganathan, et al.
Pageof 37